LAUREN DESALLE: Open Payments
NPI 1558846485 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$626 in 29 payments from 14 companies in 2025. Trend: 2023 $975 · 2024 $754 · 2025 $626
Food & beverage: $626
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $100 |
| Amgen Inc. | 4 | $91 |
| Edwards Lifesciences Corporation | 3 | $89 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $65 |
| Novartis Pharmaceuticals Corporation | 3 | $51 |
| AstraZeneca Pharmaceuticals LP | 2 | $42 |
| SCPHARMACEUTICALS INC. | 2 | $34 |
| Lilly USA, LLC | 2 | $33 |
| Kestra Medical Technology Services, Inc. | 1 | $31 |
| Boston Scientific Corporation | 1 | $19 |
Products named: REPATHA, Wegovy, JARDIANCE, LEQVIO, FARXIGA, FUROSCIX, Assure WCD, WATCHMAN.
Industry payments across PA — which companies pay providers there.
